Cancer stem cells: a metastasizing menace!

Saurabh Bandhavkar1

  • 1Department of Biochemistry, G. S. Medical College and KEM Hospital, Mumbai, Maharashtra, India.

Cancer Medicine
|January 17, 2016
PubMed

Insights

Cancer stem cells (CSCs) drive tumor growth and therapy resistance, hindering complete cures. Understanding CSCs is crucial for developing new cancer treatments and improving patient outcomes.

Area of Science:

  • Oncology
  • Cancer Biology
  • Stem Cell Research

Background:

  • Cancer remains a leading global cause of death, with current treatments often failing to provide complete cures.
  • Tumor relapse is frequently linked to a small subpopulation of cells known as cancer stem cells (CSCs).
  • CSCs possess self-renewal and differentiation capabilities, contributing to therapy resistance.

Purpose of the Study:

  • To review the key characteristics of cancer stem cells.
  • To discuss the therapeutic implications of targeting CSCs in cancer treatment.
  • To explore future perspectives in CSC-based cancer therapy.

Main Methods:

  • This review synthesizes current research on cancer stem cells.
  • It focuses on understanding CSC biology and its role in cancer progression.
  • Literature search and analysis of existing studies on CSCs were performed.

Main Results:

  • CSCs are identified as a critical factor in treatment failure and tumor recurrence.
  • Evidence suggests CSCs exhibit inherent resistance to conventional therapies like chemotherapy and radiation.
  • Targeting CSCs presents a promising strategy for more effective cancer treatment.

Conclusions:

  • Cancer stem cells represent a significant challenge in oncology due to their role in treatment resistance and relapse.
  • Further research into CSC characteristics and therapeutic targeting is essential for developing novel and curative cancer therapies.
  • Understanding and eliminating CSCs holds the potential to revolutionize cancer treatment paradigms.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.3K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Metastasis02:30

Metastasis

3.8K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
4.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K